78 related articles for article (PubMed ID: 15845614)
1. Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure.
Mayosi BM; Kardos A; Davies CH; Gumedze F; Hovnanian A; Burge S; Watkins H
Heart; 2006 Jan; 92(1):105-9. PubMed ID: 15845614
[TBL] [Abstract][Full Text] [Related]
2. Case of type 1 segmental Darier's disease with a novel mosaic mutation in the ATP2A2 gene.
Shimizu K; Fujita H; Fujisawa D; Hayama K; Aoki S; Kubo A; Terui T
J Dermatol; 2023 Aug; 50(8):e240-e242. PubMed ID: 36890674
[No Abstract] [Full Text] [Related]
3. Familial comedonal Darier's disease: a new ATP2A2 mutation with intra-family clinical heterogeneity.
Civico-Ruiz MB; Zulueta-Dorado T; López-Delgado JJ; Fernández-Rosado F; Coronel-Pérez IM; Martínez-Barranca ML
Int J Dermatol; 2023 Dec; 62(12):e620-e621. PubMed ID: 37132526
[No Abstract] [Full Text] [Related]
4. Brain-specific heterozygous loss-of-function of ATP2A2, endoplasmic reticulum Ca2+ pump responsible for Darier's disease, causes behavioral abnormalities and a hyper-dopaminergic state.
Nakajima K; Ishiwata M; Weitemier AZ; Shoji H; Monai H; Miyamoto H; Yamakawa K; Miyakawa T; McHugh TJ; Kato T
Hum Mol Genet; 2021 Aug; 30(18):1762-1772. PubMed ID: 34104969
[TBL] [Abstract][Full Text] [Related]
5. Serum SERCA2a levels in heart failure patients are associated with adverse events after discharge.
Chen P; Wu S; Hu Z; Hao B; Huang Y; Chen X; Guo Y; Wang Z; Chen X; Su M; Chen W; Zhuo Y; Li J; Wei S; Xu B; Xu J
Medicine (Baltimore); 2024 Apr; 103(16):e37761. PubMed ID: 38640274
[TBL] [Abstract][Full Text] [Related]
6. Darier's disease exhibits a unique cutaneous microbial dysbiosis associated with inflammation and body malodour.
Amar Y; Rogner D; Silva RL; Foesel BU; Ud-Dean M; Lagkouvardos I; Steimle-Grauer SA; Niedermeier S; Kublik S; Jargosch M; Heinig M; Thomas J; Eyerich S; Wikström JD; Schloter M; Eyerich K; Biedermann T; Köberle M
Microbiome; 2023 Jul; 11(1):162. PubMed ID: 37496039
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for heart failure: where do we stand?
Naim C; Yerevanian A; Hajjar RJ
Curr Cardiol Rep; 2013 Feb; 15(2):333. PubMed ID: 23307169
[TBL] [Abstract][Full Text] [Related]
8. Vesicular Darier's disease: a case report and review of the English literature of a rare disease variant.
Mourad A; Kurwa HA; Haber RM
SAGE Open Med Case Rep; 2023; 11():2050313X231195467. PubMed ID: 37654551
[TBL] [Abstract][Full Text] [Related]
9. Correction to: Brain-specific heterozygous loss-of-function of ATP2A2, endoplasmic reticulum Ca2+ pump responsible for Darier's disease, causes behavioral abnormalities and a hyper-dopaminergic state.
Hum Mol Genet; 2023 Nov; 32(22):3204. PubMed ID: 37712203
[No Abstract] [Full Text] [Related]
10. [Not Available].
Ester Molina Beltran E
Soins; 2024 Apr; 69(884):17-59. PubMed ID: 38614512
[No Abstract] [Full Text] [Related]
11. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals.
Byrne MJ; Power JM; Preovolos A; Mariani JA; Hajjar RJ; Kaye DM
Gene Ther; 2008 Dec; 15(23):1550-7. PubMed ID: 18650850
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular consequences of sickle cell disease.
Palomarez A; Jha M; Medina Romero X; Horton RE
Biophys Rev (Melville); 2022 Sep; 3(3):031302. PubMed ID: 38505276
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyocyte-specific PCSK9 deficiency compromises mitochondrial bioenergetics and heart function.
Laudette M; Lindbom M; Arif M; Cinato M; Ruiz M; Doran S; Miljanovic A; Rutberg M; Andersson L; Klevstig M; Henricsson M; Bergh PO; Bollano E; Aung N; Gustav Smith J; Pilon M; Hyötyläinen T; Orešič M; Perkins R; Mardinoglu A; Levin MC; Borén J
Cardiovasc Res; 2023 Jul; 119(7):1537-1552. PubMed ID: 36880401
[TBL] [Abstract][Full Text] [Related]
14. Preclinical models of radiation-induced cardiac toxicity: Potential mechanisms and biomarkers.
Dreyfuss AD; Velalopoulou A; Avgousti H; Bell BI; Verginadis II
Front Oncol; 2022; 12():920867. PubMed ID: 36313656
[TBL] [Abstract][Full Text] [Related]
15. Advances in Preclinical Research Models of Radiation-Induced Cardiac Toxicity.
Schlaak RA; SenthilKumar G; Boerma M; Bergom C
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32053873
[TBL] [Abstract][Full Text] [Related]
16. Primary Active Ca
Chen J; Sitsel A; Benoy V; Sepúlveda MR; Vangheluwe P
Cold Spring Harb Perspect Biol; 2020 Feb; 12(2):. PubMed ID: 31501194
[TBL] [Abstract][Full Text] [Related]
17. Structures of the heart specific SERCA2a Ca
Sitsel A; De Raeymaecker J; Drachmann ND; Derua R; Smaardijk S; Andersen JL; Vandecaetsbeek I; Chen J; De Maeyer M; Waelkens E; Olesen C; Vangheluwe P; Nissen P
EMBO J; 2019 Mar; 38(5):. PubMed ID: 30777856
[TBL] [Abstract][Full Text] [Related]
18. The human subject: an integrative animal model for 21(st) century heart failure research.
Chandrasekera PC; Pippin JJ
Am J Transl Res; 2015; 7(9):1636-47. PubMed ID: 26550463
[TBL] [Abstract][Full Text] [Related]
19. SERCA2 Haploinsufficiency in a Mouse Model of Darier Disease Causes a Selective Predisposition to Heart Failure.
Prasad V; Lorenz JN; Lasko VM; Nieman ML; Huang W; Wang Y; Wieczorek DW; Shull GE
Biomed Res Int; 2015; 2015():251598. PubMed ID: 26064889
[TBL] [Abstract][Full Text] [Related]
20. Prominent heart organ-level performance deficits in a genetic model of targeted severe and progressive SERCA2 deficiency.
Heinis FI; Andersson KB; Christensen G; Metzger JM
PLoS One; 2013; 8(11):e79609. PubMed ID: 24223976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
